title: Engineering muscle constructs for the creation of functional engineered musculoskeletal tissue.
abstract: Volumetric muscle loss (VML) is a disabling condition in which current clinical procedures are suboptimal. The field of tissue engineering has many promising strategies for the creation of functional skeletal muscle in vitro. However, there are still two key limitations that prevent it from becoming a solution for treating VML. First, engineered muscle tissue must be biocompatible to facilitate muscle tissue regrowth without generating an immune response. Second, engineered muscle constructs must be scaled up to facilitate replacement of clinically relevant volumes of tissue (centimeters in diameter). There are currently no tissue engineering strategies to produce tissue constructs that are both biocompatible and large enough to facilitate clinical repair. However, recent advances in tissue engineering using synthetic scaffolds, native scaffolds, or scaffold-free approaches may lead to a solution for repair of VML injuries.
authors.affiliation: Molecular & Integrative Physiology, University of Michigan, MI, USA.
authors.forename: Jacob P
authors.initials: JP
authors.lastname: Mertens
authors.forename: Kristoffer B
authors.initials: KB
authors.lastname: Sugg
authors.forename: Jonah D
authors.initials: JD
authors.lastname: Lee
authors.forename: Lisa M
authors.initials: LM
authors.lastname: Larkin
mesh_terms: D006801:Humans; D018482:Muscle, Skeletal / Q000502:physiology*; D020966:Muscular Disorders, Atrophic / Q000628:therapy*; D012038:Regeneration / Q000502:physiology*; D044968:Regenerative Medicine / Q000379:methods*; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry*